Page 39 - Astrazeneca Evusheld News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Two years into the pandemic Jackie Hansen still left home only for doctor visits, her...

With more of the country abandoning masks and other precautions, it's more urgent than ever to keep this forgotten group protected.

As more places drop mask orders and other COVID-19 precautions, there's new urgency in finding ways to protect up to 7 million Americans with severely weak immune systems. Vaccines don't always work for people who are immune-compromised because of cancer, organ transplants or other conditions. There's a new option, the first drug that promises to reduce the risk of COVID-19 infection for six months. Evusheld injections contain virus-fighting antibodies for people who can't make their own. But it's in short supply, restricted to the highest-risk patients.

With more of the country abandoning masks and other precautions, it's more urgent than ever to keep this forgotten group protected.

Two years into the pandemic Jackie Hansen still left home only for doctor visits, her immune system so wrecked by cancer and lupus that COVID-19 vaccinations couldn’t take hold.